T1International’s Connecticut #insulin4all Chapter brings together people living with diabetes, caregivers, and advocates working to make insulin and diabetes care more affordable and accessible.
The chapter is focused on building community power and advocating for solutions that put people with diabetes at the center of healthcare decisions. Connecticut #insulin4all has been a leader in raising awareness about the need for a different approach to insulin access, including advocating for public pharma, an approach that explores how publicly accountable systems can help ensure essential medicines are available and affordable.
Through organizing, education, and advocacy, the chapter works to highlight the experiences of people affected by high insulin costs and build support for policies that prioritize patients over profits.
What We’re Working On
Connecticut #insulin4all is focused on advancing Public Pharma solutions and building momentum for a healthcare system where essential medicines are treated as public goods.
Recent highlights include:
- Advocating for publicly accountable approaches to insulin production and access.
- Educating community members and policymakers about the role Public Pharma can play in creating more affordable healthcare solutions.
- Participating in #insulin4all campaigns and actions to raise awareness about insulin affordability.
- Connecting Connecticut advocates with the broader T1International global movement.
Who leads this group
Campbell
Campbell Mitchell has lived with Type 1 Diabetes since age nine. Growing up in Ridgefield, Campbell learned how to advocate from a young age, and now serves as Connecticut Chapter Leader, as well as conducting public health research as a Yale PhD student and advising the Connecticut state government on health policy.
